title: Erythrocyte transfusions and serum prohepcidin levels in premature newborns with anemia of prematurity.
abstract: Hepcidin is a regulatory peptide hormone acts by limiting intestinal iron absorption and promoting iron retention. Determining the level of hepcidin in anemia of prematurity might be important in preventing iron overload. This study aimed to determine serum levels of prohepcidin in newborns with anemia of prematurity, to assess the effect of a single erythrocyte transfusion on serum prohepcidin levels, and to determine the possible relationships between prohepcidin levels and serum iron and complete blood count parameters. Nineteen premature newborns with anemia of prematurity who had been treated with erythrocyte transfusions were included in this study. Just before, and 48 hours after, each transfusion, venous blood samples were collected from patients. Serum prohepcidin levels before and after erythrocyte transfusion were 206.5+/-27.3 and 205.7+/-47.1 ng/mL, respectively; no statistically significant differences were found. No significant differences existed before or after transfusion regarding serum total iron and ferritin levels, iron-binding capacity, or mean corpuscular hemoglobin concentration. No significant correlations existed between serum prohepcidin levels and other parameters, either before or after transfusions. Our results showed that there were no statistically significant differences between serum prohepcidin levels before and after a single erythrocyte transfusion in premature newborns.
authors.affiliation: Department of Pediatrics, Baskent University Faculty of Medicine, Ankara Turkey.
authors.forename: Ece
authors.initials: E
authors.lastname: Yapakçi
authors.forename: Ayşe
authors.initials: A
authors.lastname: Ecevit
authors.forename: Zeynel
authors.initials: Z
authors.lastname: Gökmen
authors.forename: Aylin
authors.initials: A
authors.lastname: Tarcan
authors.forename: Namik
authors.initials: N
authors.lastname: Ozbek
mesh_terms: D000751:Anemia, Neonatal / Q000097:blood* / Q000628:therapy*; D023181:Antimicrobial Cationic Peptides / Q000097:blood*; D017707:Erythrocyte Transfusion; D005260:Female; D005293:Ferritins / Q000097:blood; D064451:Hepcidins; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007235:Infant, Premature, Diseases / Q000097:blood* / Q000628:therapy*; D007501:Iron / Q000097:blood; D019190:Iron Overload / Q000097:blood / Q000517:prevention & control; D008297:Male; D011498:Protein Precursors / Q000097:blood*
chemical_list: D023181:Antimicrobial Cationic Peptides; D064451:Hepcidins; D011498:Protein Precursors; D005293:Ferritins; D007501:Iron